Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1626 to 1650 of about 5897

Previous 25

Website Changes

09/01/2016

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.

08/31/2016

Musella Foundation Copay Assistance Program reopens!

08/31/2016

Immunotherapy, Vaccines Offer Promise in Glioblastoma, But Data is Still Preliminary

08/31/2016

Kadmon launches mid-stage study of lead oncology candidate in brain cancer

08/25/2016

NY Islanders fundraiser for Brain Tumor Research!

08/24/2016

Update published for "Treatment Options For Glioblastoma and other Glioma"

08/23/2016

Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.

08/18/2016

Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.

08/18/2016

Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.

08/18/2016

Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.

08/16/2016

Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13

08/13/2016

MANY CANCER PATIENTS MUST FACE BANKRUPTCY—OR DIE

08/10/2016

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

08/10/2016

Call for chefs to enter Flo’s Chili Cook-Off

07/26/2016

NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma

07/26/2016

International Study Finds Effective, Less Toxic Way to Treat Brain Tumors

07/26/2016

International Study Finds Effective, Less Toxic Way to Treat Brain Tumors

07/26/2016

Musella Foundation awards $149,992 in 3 brain tumor research grants.

07/26/2016

Musella Foundation Co-payment Assistance Program is now closed to new patients

07/25/2016

NCCN updated CNS cancer treatment guidelines to include Optune

07/25/2016

Musella Foundation Co-payment Assistance Program about to close to new patients

07/23/2016

DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016

07/23/2016

Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival

07/21/2016

PD-1 blockade enhances the vaccination induced immune response in glioma

07/16/2016

Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics

Our privacy / cookie policy has changed.
Click HERE to read it!